Acceleron Pharma Inc Empfehlungs-Mittelwert
Was ist das Empfehlungs-Mittelwert von Acceleron Pharma Inc?
Empfehlungs-Mittelwert von Acceleron Pharma Inc ist 1.46
Was ist die Definition von Empfehlungs-Mittelwert?
Der empfohlene Mittelwert ist der Durchschnitt der Analystenbewertungen der Aktie von 1,0 (starker Kauf) bis 5,0 (starker Verkauf).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Empfehlungs-Mittelwert von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acceleron Pharma Inc
Was macht Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Unternehmen mit empfehlungs-mittelwert ähnlich Acceleron Pharma Inc
- China Telecom hat Empfehlungs-Mittelwert von 1.45
- T-Mobile US Inc hat Empfehlungs-Mittelwert von 1.45
- PayPal Inc hat Empfehlungs-Mittelwert von 1.45
- Taiwan Semiconductor Manufacturing hat Empfehlungs-Mittelwert von 1.45
- AECOM hat Empfehlungs-Mittelwert von 1.45
- AMN Healthcare Services hat Empfehlungs-Mittelwert von 1.45
- Acceleron Pharma Inc hat Empfehlungs-Mittelwert von 1.46
- Generac Inc hat Empfehlungs-Mittelwert von 1.47
- Nevro Corp hat Empfehlungs-Mittelwert von 1.47
- Palo Alto Networks Inc hat Empfehlungs-Mittelwert von 1.47
- Hasbro hat Empfehlungs-Mittelwert von 1.47
- Charles River Laboratories International hat Empfehlungs-Mittelwert von 1.47
- MGM Growth Properties hat Empfehlungs-Mittelwert von 1.47